Comparisons
Compare supply arrangements on the same basis.

Which arrangement fits the decision?
Manufacturer-linked branded access
- What the clinic selects or purchases
- A patient prescription and payment pathway
- When it fits
- Self-pay cohorts where published programme terms and an external checkout fit the patient journey
- What to establish before selection
- Exact product eligibility, dispensing destination, ongoing price, status visibility and support ownership
The following fit assessments are our recommended starting points, subject to the gates described later.
Read the research
What is the best GLP-1 procurement approach for a growing clinic?
Our recommendation is to compare approved-medicine dispensing arrangements first, establish a tested alternative fulfilment route, and evaluate clinic-stock purchasing only where the clinic has a specific operational reason to own inventory.
Read →Which supply-route categories should clinics compare side by side?
Compare operating models before comparing suppliers.
Read →Which current developments change the comparison?
Do not reuse a shortage-era supplier assessment or a 2025 programme-price spreadsheet without updating it.
Read →How do LillyDirect, NovoCare and an appointed pharmacy partner compare?
Manufacturer-linked access can be a useful patient pathway without being a clinic wholesale relationship.
Read →What published GLP-1 cash prices are useful comparison anchors?
Use public prices to test patient affordability, not to infer clinic acquisition cost or negotiate from an assumed wholesale margin.
Read →How should clinics compare 503A and 503B GLP-1 compounding?
Treat 503A and 503B as distinct legal frameworks, not supplier quality tiers or interchangeable routes to lower prices.
Read →How should a CFO compare the full cost of patient access?
Maintain separate clinic, patient and payer ledgers.
Read →Which eligibility and quality checks must come before commercial scoring?
Use a pass/hold gate.
Read →Should the clinic use one pharmacy, two pharmacies, or a routing platform?
Our preferred starting design is a primary route plus a validated fallback—not automatic equal splitting and not untested exclusivity.
Read →11 pages shown
Research quality self-assessment
The research’s own assessment; not an external rating.